Fimasartan: all 49 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and HypertensionRecruitingNCT05173025Phase 4
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male SubjectsCompletedNCT02704702Phase 1Results posted
• Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial HypertensionCompletedNCT02248961Phase 3Results posted
• Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension PatientsCompletedNCT00922480Phase 3Results posted
• A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential HypertensionCompletedNCT00922441Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary HypercholesterolemiaCompletedNCT05930028Phase 3
• A Study to Evaluate the Efficacy and Safety of BR1015 Combination TherapyCompletedNCT05878561Phase 3
• A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy VolunteersCompletedNCT05097794Phase 1
• BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine CombinationCompletedNCT03991442Phase 3
• A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03338426Phase 3
• Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With HypertensionStatus unknownNCT03294070Phase 4
• Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and DyslipidemiaCompletedNCT03156842Phase 3
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.CompletedNCT02994745Phase 1
• Comparison of Blood Pressure Lowering Effect Between Fimasartan and LosartanStatus unknownNCT02958631Phase 4
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male SubjectsCompletedNCT02920047Phase 1
• A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/RosuvastatinCompletedNCT02569814Phase 1
• A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination TabletCompletedNCT02566187Phase 1
• Fimasartan Achieving SBP Target (FAST) StudyCompletedNCT02495324Phase 4
• Efficacy and Safety of Fimasartan Alone or Combined With HCTZ in Mexican Patients With Essential HypertensionCompletedNCT02466490Phase 3
• Comparison of Peripheral and Cerebral Arterial Flow in Acute Ischemic Stroke: Fimasartan vs. Valsartan vs. AtenololStatus unknownNCT02403349Phase 4
• Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male VolunteersCompletedNCT02397590Phase 1
• Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male SubjectsCompletedNCT02397538Phase 1
• Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic PatientsCompletedNCT02312375Not applicable
• A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/HydrochlorothiazideCompletedNCT02222480Phase 2
• to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and RosuvastatinCompletedNCT02205190Phase 1
• To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual TabletsCompletedNCT02205151Phase 1
• A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and DyslipidemiaCompletedNCT02166814Phase 3
• Fimasartan/Amlodipine Combination Phase IIICompletedNCT02152306Phase 3
• To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and RosuvastatinCompletedNCT01921946Phase 1
• A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential HypertensionCompletedNCT01878201Phase 2
• Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan and Atenolol With Exaggerated Blood Pressure Response During Exercise in Essential Hypertensive PatientsCompletedNCT01736488Phase 4
• A Trial of Fimasartan for Early Diastolic Heart FailureCompletedNCT01691118Phase 4
• A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential HypertensionCompletedNCT01672476Phase 3
• Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy SubjectsCompletedNCT01671020Phase 1
• A Randomized Trial of Angiotensin Receptor bLocker,Fimasartan, in Aortic Stenosis (ALFA Trial)Status unknownNCT01589380Phase 4
• Effect of Fimasartan for Modification of Atheroma Vulnerability in DEFERred Coronary Disease (FIMA-DEFER)TerminatedNCT01384747Phase 4
• Fimasartan (BR-A-657) Multiple Oral Dose in Healthy SubjectsCompletedNCT01289899Phase 1
• Fimasartan (BR-A-657) Single Oral Dose in Healthy SubjectsCompletedNCT01289886Phase 1
• A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy VolunteersCompletedNCT01148368Phase 1
• A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy VolunteersCompletedNCT01146938Phase 1
• The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential HypertensionCompletedNCT01135212Phase 3
• A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT01007409Phase 1
• A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male VolunteersCompletedNCT00991783Phase 1
• A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male VolunteersCompletedNCT00991705Phase 1
• A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male VolunteersCompletedNCT00938197Phase 1
• A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male VolunteersCompletedNCT00938132Phase 1
• Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male VolunteersCompletedNCT00937534Phase 1
• Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension PatientsCompletedNCT00923611Phase 2
• A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male VolunteersCompletedNCT00923533Phase 1

← Fimasartan overview